Citations

Showing 10 of 108119 citations.

Epidemiology of Childhood‐Onset Systemic Lupus Erythematosus: A Population‐Based Study
Valenzuela-Almada, Maria O , Hocaoǧlu, Mehmet , Dabit, Jesse Y. , Osei‐Onomah, Shirley‐Ann, Basiaga, Matthew L. , Giblon, Rachel , Crowson, Cynthia S. , Duarte‐García, Alí , Orandi, Amir B. , Giblon, Rachel E., Barbour, Kamil E , Crowson, CS , Duarte-García, Alí

Mayo Clinic

Arthritis Care & Research | November 26, 2021 | Volume: 74 | Issue: 5 | Pages: 728-732

10.1002/acr.24827 | PMID 34825516 Get It

Objective To characterize the incidence and prevalence of childhood‐onset systemic lupus erythematosus (SLE), and to estimate the proportion of patients who are diagnosed with SLE during childhood. Methods A cohort of patients with incident childhood‐onset SLE from 1976 to 2018 from an 8‐county region in the US were identified based on comprehensive medical record review. All patients met the European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) classification criteria for SLE or the ACR SLE classification criteria from 1997 at or before age 18 years. Incidence rates were estimated using Poisson methods. We estimated the childhood‐onset SLE point prevalence for January 1, 2015. Results were sex and age adjusted to the US 2000 population. Among all the SLE patients living in the 8‐county region on January 1, 2015, the proportion of patients diagnosed at ≤18 years was estimated. Results A total of 13 children were diagnosed with childhood‐onset SLE during the study period (using the EULAR/ACR definition; mean age at diagnosis 15.1 years, 85% female, 69% White). Childhood‐onset SLE overall adjusted incidence rate was 0.7 (95% confidence interval [95% CI] 0.2–1.1) per 100,000 children. The incidence rate in girls was 1.2 (95% CI 0.5–1.9) per 100,000 children, while in boys it was 0.2 (95% CI 0.0–0.5) per 100,000. The adjusted prevalence of childhood‐onset SLE was 1.1 (95% CI 0.0–3.1) per 100,000 children. The proportion of patients with SLE diagnosed as children was 9% (95% CI 6–13%). Conclusion In this population‐based study, both the incidence and prevalence rates of childhood‐onset SLE were ~1 per 100,000 children. One in 10 adults with SLE was diagnosed in childhood. More studies are needed to further characterize the epidemiology of childhood‐onset SLE in minorities.
Hybrid surgery: a comparison of early postoperative outcomes between anterior cervical discectomy and fusion and cervical disc arthroplasty
Michalopoulos, Giorgos D. , Bhandarkar, Archis R. , Jarrah, Ryan , Yolcu, Yagiz U. , Alvi, Mohammed Ali , Sebastian, Arjun S. , Freedman, Brett A. , Bydon, Mohamad , Yolcu, Yagiz Ugur, Alvi, Mohammed Ali , Michalopoulos, Giorgos , Ghaith, Abdul Karim

Mayo Clinic

Journal of Neurosurgery: Spine | November 26, 2021 | Volume: 36 | Issue: 4 | Pages: 575-584

10.3171/2021.7.spine21478 | PMID 34715670 Get It

OBJECTIVE Hybrid surgery (HS) is the combination of anterior cervical discectomy and fusion (ACDF) and cervical disc arthroplasty (CDA) at different levels in the same operation. The aim of this study was to investigate perioperative variables, 30-day postoperative outcomes, and complications of HS in comparison with those of CDA and ACDF. METHODS The authors queried the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) registry for patients who underwent multilevel primary HS, CDA, and ACDF for degenerative disc disease from 2015 to 2019. The authors compared these three operations in terms of 30-day postoperative outcomes, specifically readmission and reoperation rates, discharge destination, and complications. RESULTS This analysis included 439 patients who underwent HS, 976 patients who underwent CDA, and 27,460 patients who underwent ACDF. Patients in the HS and CDA groups were younger, had fewer comorbidities, and myelopathy was less often the indication for surgery compared with patients who underwent ACDF. For the HS group, the unplanned readmission rate was 0.7%, index surgery–related reoperation rate was 0.3%, and nonroutine discharge rate was 2.1%. Major and minor complications were also rare, with rates of 0.2% for each. The mean length of stay in the HS group was 1.5 days. The association of HS with better outcomes in univariate analysis was not evident after adjustment for confounding factors. CONCLUSIONS The authors found that HS was noninferior to ACDF and CDA in terms of early postoperative outcomes among patients treated for degenerative disc disease.
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology
Koga, Shunsuke , Zhou, Xiaolai , Murakami, Aya , Castro, Cristhoper Fernandez De, Rademakers, Rosa , Dickson, Dennis W. , Fernandez De Castro, Cristhoper, Baker, Matthew C, Dickson, Dennis W , Koga, Shunsuke , Baker, Matthew

Mayo Clinic

Neuropathology and Applied Neurobiology | November 25, 2021 | Volume: 48 | Issue: 2 | Pages: No page available

10.1111/nan.12778 | PMID 34823271 Get It

Abstract Aims Accumulating evidence suggests that patients with frontotemporal lobar degeneration (FTLD) can have pathologic accumulation of multiple proteins, including tau and TDP‐43. This study aimed to determine the frequency and characteristics of concurrent tau pathology in FTLD with TDP‐43 pathology (FTLD‐TDP). Methods The study included 146 autopsy‐confirmed cases of FTLD‐TDP and 55 cases of FTLD‐TDP with motor neuron disease (FTLD‐MND). Sections from the basal forebrain were screened for tau pathology with phosphorylated‐tau immunohistochemistry. For cases with tau pathology on the screening section, additional brain sections were studied to establish a diagnosis. Genetic analysis of C9orf72 , GRN and MAPT was performed on select cases. Results We found 72 cases (36%) with primary age‐related tauopathy (PART), 85 (42%) with ageing‐related tau astrogliopathy (ARTAG), 45 (22%) with argyrophilic grain disease (AGD) and 2 cases (1%) with corticobasal degeneration (CBD). Patients with ARTAG or AGD were significantly older than those without these comorbidities. One of the patients with FTLD‐TDP and CBD had C9orf72 mutation and relatively mild tau pathology, consistent with incidental CBD. Conclusion The coexistence of TDP‐43 and tau pathologies was relatively common, particularly PART and ARTAG. Although rare, patients with FTLD can have multiple neurodegenerative proteinopathies. The absence of TDP‐43‐positive astrocytic plaques may suggest that CBD and FTLD‐TDP were independent disease processes in the two patients with both tau and TDP‐43 pathologies. It remains to be determined if mixed cases represent a unique disease process or two concurrent disease processes in an individual.
Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients
Arribas, Mariano , Ahmann, Greg, Petty, Skye Buckner , Braggio, Esteban , Theel, Elitza S. , Ahmann, Greg J, Buckner Petty, Skye, Braggio, Esteban , Fonseca, Rafaël

Mayo Clinic

American Journal of Hematology | November 25, 2021 | Volume: 97 | Issue: 2 | Pages: No page available

10.1002/ajh.26421 | PMID 34822201 Get It

Deciphering the individual contribution of absolute neutrophil and monocyte counts to thrombosis risk in polycythemia vera and essential thrombocythemia
Farrukh, Faiqa, Loscocco, Giuseppe Gaetano , Pardanani, Animesh , Hanson, Curtis A. , Stefano, Valerio De , Barbui, Tiziano , Gangat, Naseema , Vannucchi, Alessandro M. , Tefferi, Ayalew , Loscocco, Giuseppe Gaetano , Pardanani, Animesh , De Stefano, Valerio , Barbui, Tiziano , Gangat, Naseema , Vannucchi, Alessandro M , Tefferi, Ayalew , Guglielmelli, Paola

Mayo Clinic

American Journal of Hematology | November 25, 2021 | Volume: 97 | Issue: 2 | Pages: No page available

10.1002/ajh.26423 | PMID 34822188 Get It

Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study
Blumberg, Emily A. , Collins, Gary , Young, Jo‐Anne H. , Michonneau, David , Temesgen, Zelalem , Origüen, Julia , Barcán, Laura , Obeid, Karam M. , Belloso, Waldo , Corbelli, Giulio Maria , Neaton, James D. , Lundgren, Jens , Molina, Jean‐Michel , Group, for the INSIGHT Clostridioides difficile Study, Michonneau, David , Temesgen, Zelelem , Obeid, Karam M , Belloso, Waldo H , Gras, Julien , Corbelli, Giulio Maria , Lundgren, Jens , Snydman, D R , Young, Jo-Anne H , Nguyen, M Hong , Snydman, David R. , Group, for the INSIGHT Clostridioides difficile Study

Mayo Clinic

Transplant Infectious Disease | November 25, 2021 | Volume: 24 | Issue: 1 | Pages: No page available

10.1111/tid.13770 | PMID 34821423 Get It

AbstractBackgroundClostridioides difficile infection (CDI) is a significant cause of morbidity and mortality in recipients of solid organ transplant (SOT) or hematopoietic stem cell transplant (HSCT). In retrospective single center analyses, severe disease and relapse are common. We undertook an international, prospective cohort study to estimate the response to physician determined antibiotic treatment for CDI in patients with SOT and HSCT.MethodsAdults with a first episode of CDI within the first 2 years of SOT or HSCT were enrolled. Demographics, comorbidities, and medication history were collected, and over 90 days of follow‐up clinical cure, recurrences, and complications were assessed. Logistic regression was used to study associations of baseline predictors of clinical cure and recurrence. Odds ratios (ORs) and 95% confidence intervals (CIs) are cited.ResultsA total of 132 patients, 81 SOT and 51 HSCT (32 allogeneic), were enrolled with a median age of 56 years; 82 (62%) were males and 128 (97%) were hospitalized at enrollment. One hundred and six (80.3%) were diagnosed by DNA assay. CDI occurred at a median of 20 days post‐transplant (interquartile range, IQR: 6–133). One hundred and eight patients (81.8%) were on proton pump inhibitors; 126 patients (95.5%) received antibiotics within the 6 weeks before CDI. The most common initial CDI treatments prescribed, on or shortly before enrollment, were oral vancomycin alone (50%) and metronidazole alone (36%). Eighty‐three percent (95% CI: 76, 89) of patients had clinical cure; 18% (95% CI: 12, 27) of patients had recurrent CDI; global clinical cure occurred in 65.2%. Of the 11 patients who died, two (1.5% of total) were related to CDI. In multivariable logistic regression analyses, the type of initial treatment was associated with clinical cure (p = .009) and recurrence (p = .014). A history of cytomegalovirus (CMV) after transplant was associated with increased risk of recurrence (44% with versus 13% without CMV history; OR: 5.7, 95% CI: 1.5, 21.3; p = .01).ConclusionsAmong adults who develop CDI after SOT or HSCT, despite their immunosuppressed state, the percentage with clinical cure was high and the percentage with recurrence was low. Clinical cure and recurrence varied by type of initial treatment, and CMV viremia/disease was associated with an increased risk of recurrence.
Accuracy of the International Classification of Diseases, 9th Revision for Identifying Infantile Eye Disease
Xu, Timothy T. , Bothun, Cole E. , Hendricks, Tina M., Mansukhani, Sasha A. , Bothun, Erick D. , White, Launia J. , Mohney, Brian G.

Mayo Clinic

Ophthalmic Epidemiology | November 25, 2021 | Volume: 29 | Issue: 6 | Pages: 649-655

10.1080/09286586.2021.2009520 | PMID 34821545 Get It

The mechanisms and therapeutic targets of ferroptosis in cancer
Ye, Long , Jin, Fengyan , Kumar, Shaji , Dai, Yun , Kumar, Shaji K , Dai, Yun , Ye, Long

Mayo Clinic

Expert Opinion on Therapeutic Targets | November 25, 2021 | Volume: 25 | Issue: 11 | Pages: 965-986

10.1080/14728222.2021.2011206 | PMID 34821176 Get It

Fatty acid metabolism in adaptive immunity
Zhu, Xingxing , Zeng, Hu , Zeng, Hu , Zhu, Xingxing , Zhou, Xian

Mayo Clinic

The FEBS Journal | November 25, 2021 | Volume: 290 | Issue: 3 | Pages: 584-599

10.1111/febs.16296 | PMID 34822226 Get It

Fatty acids (FAs) not only are a key component of cellular membrane structure, but also have diverse functions in biological processes. Recent years have seen great advances in understanding of how FA metabolism contributes to adaptive immune response. Here, we review three key processes, FA biosynthesis, FA oxidation and FA uptake, and how they direct T and B cell functions during immune challenges. Then, we will focus on the relationship between microbiota derived FAs, short‐chain FAs, and adaptive immunity. Along the way, we will also discuss the outstanding controversies and challenges in the field.
Urinary leukotriene E4 is a biomarker for chronic rhinosinusitis associated with leukotriene dysregulation irrespective of aspirin sensitivity status
Idler, Beau M. , Lal, Devyani , Marino, Michael J. , Lal, Devyani

Mayo Clinic

International Forum of Allergy & Rhinology | November 25, 2021 | Volume: 12 | Issue: 5 | Pages: 805-808

10.1002/alr.22915 | PMID 34821062 Get It